TIMP2 and neoplasm: We demonstrated, in the in vivo experimental model, that complexes containing AP-15 and pTIMP2 administered to mice bearing B16-F10 or L1 tumors introduced the TIMP2 gene to tumor cells with high efficiency (Fig 7a and 7b).